Jenburkt Pharmaceuticals Limited Revenue and Competitors

Mumbai, IND

Location

N/A

Total Funding

Industry

Employee Data

  • Jenburkt Pharmaceuticals Limited has 199 Employees.(i)
  • Jenburkt Pharmaceuticals Limited grew their employee count by 16% last year.

Jenburkt Pharmaceuticals Limited's People

NameTitleEmail/Phone
1
General Manager-QA/QCReveal Email/Phone

What Is Jenburkt Pharmaceuticals Limited?

Our purpose at Jenburkt Pharmaceuticals Ltd is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. We believe in serving our patients – through them, we serve God, humanity and nation. Way back in the twentieth century, a visionary in the field of healthcare and philanthropic work – Shri Nandlal Mulji Bhuta laid the foundation for several companies. Today, with over 850+ committed team members across functions pan-India,we have 11 million+ prescriptions generated annually from 400,000+ pharmacies across the globe. Our organisation caters to large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. We enjoy an international presence, with our products exported to 13 countries globally including niche segments. In an ever-changing health landscape, our rapt attention to market trends, innovation, our keen focus on quality above all else, and our team's restless perseverance to deliver ground-breaking new healthcare solutions set us apart.

keywords:N/A

N/A

Total Funding

199

Number of Employees

N/A

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Jenburkt Pharmaceuticals Limited News

2022-03-30 - Jenburkt Wellness launches D2C brand Zixa Strong - An innovative, fast-acting pain relief range

About Jenburkt Pharmaceuticals Ltd. Founded in 1985, Jenburkt Pharmaceuticals Ltd. is a public-listed pharmaceutical organisation headquartered...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.7M199N/AN/A
#2
N/A1993%N/A
#3
N/A1996%N/A
#4
$22.4M1990%N/A
#5
$44M19928%N/A